Molecular profiling in cholangiocarcinoma: a practical guide to next-generation sequencing
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular profiling in cholangiocarcinoma: a practical guide to next-generation sequencing
Authors
Keywords
-
Journal
CANCER TREATMENT REVIEWS
Volume -, Issue -, Pages 102649
Publisher
Elsevier BV
Online
2023-10-31
DOI
10.1016/j.ctrv.2023.102649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Tumor Board at European Institute of Oncology: report of the first three year activity of an Italian precision oncology experience.
- (2023) Matteo Repetto et al. EUROPEAN JOURNAL OF CANCER
- Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
- (2023) Lipika Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
- (2023) Olaf Neumann et al. Journal of Pathology Clinical Research
- ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma
- (2022) Helena Verdaguer et al. CLINICAL CANCER RESEARCH
- Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
- (2022) Peter Horak et al. GENETICS IN MEDICINE
- Molecular and radio‐pathologic spectrum between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- (2022) Youngsic Jeon et al. HEPATOLOGY
- The emerging roles of NGS in clinical oncology and personalized medicine
- (2022) Bashdar Mahmud Hussen et al. PATHOLOGY RESEARCH AND PRACTICE
- Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
- (2022) May T. Cho et al. Cancers
- Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
- (2022) Denis Horgan et al. Journal of Personalized Medicine
- Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
- (2022) Do-Youn Oh et al. Lancet Gastroenterology & Hepatology
- Promising Genomic Testing for Biliary Tract Cancer Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy Specimens
- (2022) Masaki Kuwatani et al. Diagnostics
- FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint
- (2022) Filippo Cappello et al. Journal of Personalized Medicine
- Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients treated in Europe
- (2022) Angela Lamarca et al. ANNALS OF ONCOLOGY
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
- (2022) J. Pascual et al. ANNALS OF ONCOLOGY
- Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
- (2022) Olaf Neumann et al. BRITISH JOURNAL OF CANCER
- An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
- (2022) David C Madoff et al. ONCOLOGIST
- Target Enrichment Approaches for Next-Generation Sequencing Applications in Oncology
- (2022) Rajesh R. Singh Diagnostics
- Role of molecular genetics in the clinical management of cholangiocarcinoma
- (2022) N. Normanno et al. ESMO Open
- The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
- (2022) J.E. Berchuck et al. ANNALS OF ONCOLOGY
- Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study
- (2022) Rochelle Payne Ondracek et al. BMC GENOMICS
- Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
- (2022) Aurelie Tomczak et al. BRITISH JOURNAL OF CANCER
- Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- (2022) A. Vogel et al. ANNALS OF ONCOLOGY
- Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
- (2022) Alexander Scheiter et al. BRITISH JOURNAL OF CANCER
- Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma
- (2022) Gajanan Kendre et al. JOURNAL OF HEPATOLOGY
- Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations
- (2022) K. Murugesan et al. ESMO Open
- Next generation sequencing for biliary tract cancers
- (2021) Timothy P. DiPeri et al. Expert Review of Gastroenterology & Hepatology
- Allelic Dropout Is a Common Phenomenon That Reduces the Diagnostic Yield of PCR-Based Sequencing of Targeted Gene Panels
- (2021) Anna G. Shestak et al. Frontiers in Genetics
- Practical considerations in screening for genetic alterations in cholangiocarcinoma
- (2021) T.S. Bekaii-Saab et al. ANNALS OF ONCOLOGY
- Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and PD‐1/PD‐L1 Blockade Responses
- (2021) Jihoon G. Yoon et al. HEPATOLOGY
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- Next-Generation Biomarkers for Cholangiocarcinoma
- (2021) Pedro M. Rodrigues et al. Cancers
- Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer
- (2021) Jin-Yi Han et al. Cancers
- Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review
- (2021) Rohan Shotton et al. World Journal of Gastrointestinal Oncology
- Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
- (2021) D.M. Vega et al. ANNALS OF ONCOLOGY
- Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer
- (2021) Q. Gou et al. ESMO Open
- Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma
- (2021) Yuanwen Zheng et al. Journal of Gastrointestinal Oncology
- Clinical and translational research challenges in biliary tract cancers.
- (2020) Angela Lamarca et al. CURRENT MEDICINAL CHEMISTRY
- The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology
- (2020) Xavier Matias-Guiu et al. VIRCHOWS ARCHIV
- Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications
- (2020) Raffaella Pasquale et al. Translational Lung Cancer Research
- Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
- (2020) Angela Lamarca et al. JOURNAL OF HEPATOLOGY
- Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
- (2020) Robert Montal et al. JOURNAL OF HEPATOLOGY
- A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
- (2020) Alex H. Wagner et al. NATURE GENETICS
- Comprehensive Genomic Landscape and Precision Therapeutic Approach in Biliary Tract Cancers
- (2020) Ryosuke Okamura et al. INTERNATIONAL JOURNAL OF CANCER
- Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion
- (2020) William Mathieson et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
- (2020) Rossella Bruno et al. Diagnostics
- Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers
- (2020) Wei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention
- (2020) Antonella De Luca et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers
- (2020) Angela Lamarca et al. Journal of Clinical Medicine
- Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma
- (2020) Andrea Necchi et al. European Urology Focus
- Pathogenesis of Cholangiocarcinoma
- (2020) Pedro M. Rodrigues et al. Annual Review of Pathology-Mechanisms of Disease
- Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
- (2020) Melanie A. Krook et al. BRITISH JOURNAL OF CANCER
- Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
- (2020) Ian M. Silverman et al. Cancer Discovery
- Bile-Based Cell-Free DNA Analysis Is a Reliable Diagnostic Tool in Pancreatobiliary Cancer
- (2020) Caroline Driescher et al. Cancers
- Clinical presentation, diagnosis and staging of cholangiocarcinoma
- (2019) Alejandro Forner et al. LIVER INTERNATIONAL
- Anatomical, histomorphological, and molecular classification of cholangiocarcinoma
- (2019) Timothy Kendall et al. LIVER INTERNATIONAL
- Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures
- (2019) Aatur D Singhi et al. GUT
- TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma
- (2019) Lipika Goyal et al. Cancer Discovery
- An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer
- (2019) Brian C. Haynes et al. Translational Oncology
- Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
- (2019) Michael Seager et al. Jove-Journal of Visualized Experiments
- Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics
- (2019) Anna Petrackova et al. Frontiers in Oncology
- Molecular classification of cholangiocarcinoma
- (2019) Corentin Louis et al. CURRENT OPINION IN GASTROENTEROLOGY
- National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue
- (2018) Sarah R. Greytak et al. BIOPRESERVATION AND BIOBANKING
- Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing
- (2018) Laura E. MacConaill et al. BMC GENOMICS
- Comprehensive molecular profiling of intra- and extrahepatic cholangiocarcinomas: potential targets for intervention
- (2018) Maeve A Lowery et al. CLINICAL CANCER RESEARCH
- Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus
- (2018) Alexa B. Schrock et al. CLINICAL CANCER RESEARCH
- Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management
- (2018) Stacy S. Hung et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Comparison of biliary brush biopsy and fine needle biopsy in the diagnosis of biliary strictures
- (2018) Adrian Gonzalez-Aguirre et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform
- (2018) Scott Morris et al. PLoS One
- National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue
- (2018) Sarah R. Greytak et al. Biopreservation and Biobanking
- Whole-Genome Sequencing in Cancer
- (2018) Eric Y. Zhao et al. Cold Spring Harbor Perspectives in Medicine
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2018) J Mateo et al. ANNALS OF ONCOLOGY
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
- (2018) Alexa B. Schrock et al. Journal of Thoracic Oncology
- Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial
- (2017) Loic Verlingue et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
- (2017) Lawrence J. Jennings et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Clinical application of a cancer genomic profiling assay to guide precision medicine decisions
- (2017) Cheryl Eifert et al. Personalized Medicine
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center’s experiences
- (2017) Minho Cho et al. Oncotarget
- Genomic Profiling of Small-Bowel Adenocarcinoma
- (2017) Alexa B. Schrock et al. JAMA Oncology
- Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment
- (2016) Somak Roy et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Biliary cancer: Utility of next-generation sequencing for clinical management
- (2016) Milind Javle et al. CANCER
- Next-Generation Sequencing in Cancer Diagnostics
- (2016) Christopher L. Corless JOURNAL OF MOLECULAR DIAGNOSTICS
- Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
- (2016) Zandra C Deans et al. VIRCHOWS ARCHIV
- Polyclonal SecondaryFGFR2Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
- (2016) Lipika Goyal et al. Cancer Discovery
- Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors
- (2016) Katherine Geiersbach et al. Cancer Genetics
- Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
- (2016) Anna Maria Rachiglio et al. Oncotarget
- Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
- (2015) Bastiaan BJ Tops et al. BMC CANCER
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing
- (2015) Eric Samorodnitsky et al. HUMAN MUTATION
- Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets
- (2015) Hwajeong Lee et al. JOURNAL OF CLINICAL PATHOLOGY
- Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
- (2014) H. Do et al. CLINICAL CHEMISTRY
- Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing
- (2014) Carolyn J. Shiau et al. Journal of Thoracic Oncology
- The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
- (2013) Alexander J J Smits et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started